2024-06-012025-05-312025-05-31false10207865FN BLOODSTOCK LIMITED2026-05-2901430falseiso4217:GBPxbrli:pure102078652024-05-31102078652025-05-31102078652024-06-012025-05-31102078652023-05-31102078652024-05-31102078652023-06-012024-05-3110207865bus:SmallEntities2024-06-012025-05-3110207865bus:AuditExempt-NoAccountantsReport2024-06-012025-05-3110207865bus:FullAccounts2024-06-012025-05-3110207865bus:PrivateLimitedCompanyLtd2024-06-012025-05-3110207865core:WithinOneYear2025-05-3110207865core:AfterOneYear2025-05-3110207865core:WithinOneYear2024-05-3110207865core:AfterOneYear2024-05-3110207865core:ShareCapital2025-05-3110207865core:SharePremium2025-05-3110207865core:RevaluationReserve2025-05-3110207865core:OtherReservesSubtotal2025-05-3110207865core:RetainedEarningsAccumulatedLosses2025-05-3110207865core:ShareCapital2024-05-3110207865core:SharePremium2024-05-3110207865core:RevaluationReserve2024-05-3110207865core:OtherReservesSubtotal2024-05-3110207865core:RetainedEarningsAccumulatedLosses2024-05-3110207865core:LandBuildings2025-05-3110207865core:PlantMachinery2025-05-3110207865core:Vehicles2025-05-3110207865core:FurnitureFittings2025-05-3110207865core:OfficeEquipment2025-05-3110207865core:NetGoodwill2025-05-3110207865core:IntangibleAssetsOtherThanGoodwill2025-05-3110207865core:ListedExchangeTraded2025-05-3110207865core:UnlistedNon-exchangeTraded2025-05-3110207865core:LandBuildings2024-05-3110207865core:PlantMachinery2024-05-3110207865core:Vehicles2024-05-3110207865core:FurnitureFittings2024-05-3110207865core:OfficeEquipment2024-05-3110207865core:NetGoodwill2024-05-3110207865core:IntangibleAssetsOtherThanGoodwill2024-05-3110207865core:ListedExchangeTraded2024-05-3110207865core:UnlistedNon-exchangeTraded2024-05-3110207865core:LandBuildings2024-06-012025-05-3110207865core:PlantMachinery2024-06-012025-05-3110207865core:Vehicles2024-06-012025-05-3110207865core:FurnitureFittings2024-06-012025-05-3110207865core:OfficeEquipment2024-06-012025-05-3110207865core:NetGoodwill2024-06-012025-05-3110207865core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3110207865core:ListedExchangeTraded2024-06-012025-05-3110207865core:UnlistedNon-exchangeTraded2024-06-012025-05-3110207865core:MoreThanFiveYears2024-06-012025-05-3110207865core:Non-currentFinancialInstruments2025-05-3110207865core:Non-currentFinancialInstruments2024-05-3110207865dpl:CostSales2024-06-012025-05-3110207865dpl:DistributionCosts2024-06-012025-05-3110207865core:LandBuildings2024-06-012025-05-3110207865core:PlantMachinery2024-06-012025-05-3110207865core:Vehicles2024-06-012025-05-3110207865core:FurnitureFittings2024-06-012025-05-3110207865core:OfficeEquipment2024-06-012025-05-3110207865dpl:AdministrativeExpenses2024-06-012025-05-3110207865core:NetGoodwill2024-06-012025-05-3110207865core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3110207865dpl:GroupUndertakings2024-06-012025-05-3110207865dpl:ParticipatingInterests2024-06-012025-05-3110207865dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-012025-05-3110207865core:ListedExchangeTraded2024-06-012025-05-3110207865dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-012025-05-3110207865core:UnlistedNon-exchangeTraded2024-06-012025-05-3110207865dpl:CostSales2023-06-012024-05-3110207865dpl:DistributionCosts2023-06-012024-05-3110207865core:LandBuildings2023-06-012024-05-3110207865core:PlantMachinery2023-06-012024-05-3110207865core:Vehicles2023-06-012024-05-3110207865core:FurnitureFittings2023-06-012024-05-3110207865core:OfficeEquipment2023-06-012024-05-3110207865dpl:AdministrativeExpenses2023-06-012024-05-3110207865core:NetGoodwill2023-06-012024-05-3110207865core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3110207865dpl:GroupUndertakings2023-06-012024-05-3110207865dpl:ParticipatingInterests2023-06-012024-05-3110207865dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3110207865core:ListedExchangeTraded2023-06-012024-05-3110207865dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3110207865core:UnlistedNon-exchangeTraded2023-06-012024-05-3110207865core:NetGoodwill2025-05-3110207865core:IntangibleAssetsOtherThanGoodwill2025-05-3110207865core:LandBuildings2025-05-3110207865core:PlantMachinery2025-05-3110207865core:Vehicles2025-05-3110207865core:FurnitureFittings2025-05-3110207865core:OfficeEquipment2025-05-3110207865core:AfterOneYear2025-05-3110207865core:WithinOneYear2025-05-3110207865core:ListedExchangeTraded2025-05-3110207865core:UnlistedNon-exchangeTraded2025-05-3110207865core:ShareCapital2025-05-3110207865core:SharePremium2025-05-3110207865core:RevaluationReserve2025-05-3110207865core:OtherReservesSubtotal2025-05-3110207865core:RetainedEarningsAccumulatedLosses2025-05-3110207865core:NetGoodwill2024-05-3110207865core:IntangibleAssetsOtherThanGoodwill2024-05-3110207865core:LandBuildings2024-05-3110207865core:PlantMachinery2024-05-3110207865core:Vehicles2024-05-3110207865core:FurnitureFittings2024-05-3110207865core:OfficeEquipment2024-05-3110207865core:AfterOneYear2024-05-3110207865core:WithinOneYear2024-05-3110207865core:ListedExchangeTraded2024-05-3110207865core:UnlistedNon-exchangeTraded2024-05-3110207865core:ShareCapital2024-05-3110207865core:SharePremium2024-05-3110207865core:RevaluationReserve2024-05-3110207865core:OtherReservesSubtotal2024-05-3110207865core:RetainedEarningsAccumulatedLosses2024-05-3110207865core:NetGoodwill2023-05-3110207865core:IntangibleAssetsOtherThanGoodwill2023-05-3110207865core:LandBuildings2023-05-3110207865core:PlantMachinery2023-05-3110207865core:Vehicles2023-05-3110207865core:FurnitureFittings2023-05-3110207865core:OfficeEquipment2023-05-3110207865core:AfterOneYear2023-05-3110207865core:WithinOneYear2023-05-3110207865core:ListedExchangeTraded2023-05-3110207865core:UnlistedNon-exchangeTraded2023-05-3110207865core:ShareCapital2023-05-3110207865core:SharePremium2023-05-3110207865core:RevaluationReserve2023-05-3110207865core:OtherReservesSubtotal2023-05-3110207865core:RetainedEarningsAccumulatedLosses2023-05-3110207865core:AfterOneYear2024-06-012025-05-3110207865core:WithinOneYear2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:CostValuation2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-012025-05-3110207865core:Non-currentFinancialInstrumentscore:CostValuation2025-05-3110207865core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-05-3110207865core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3110207865core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3110207865core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3110207865bus:Director12024-06-012025-05-31

FN BLOODSTOCK LIMITED

Registered Number
10207865
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2025

FN BLOODSTOCK LIMITED
Company Information
for the year from 1 June 2024 to 31 May 2025

Director

POSTE, Francesca Alice

Company Secretary

KEATLEY, Michael

Registered Address

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF

Registered Number

10207865 (England and Wales)
FN BLOODSTOCK LIMITED
Balance Sheet as at
31 May 2025

Notes

2025

2024

£

£

£

£

Current assets
Stocks342,05034,234
Debtors615,223137,023
Cash at bank and on hand109,3031,065,890
766,5761,237,147
Creditors amounts falling due within one year4(786,940)(1,333,069)
Net current assets (liabilities)(20,364)(95,922)
Total assets less current liabilities(20,364)(95,922)
Net assets(20,364)(95,922)
Capital and reserves
Called up share capital11
Profit and loss account(20,365)(95,923)
Shareholders' funds(20,364)(95,922)
The financial statements were approved and authorised for issue by the Director on 29 May 2026, and are signed on its behalf by:
POSTE, Francesca Alice
Director
Registered Company No. 10207865
FN BLOODSTOCK LIMITED
Notes to the Financial Statements
for the year ended 31 May 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Stocks and work in progress
Inventories are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20252024
Average number of employees during the year00
3.Stocks

2025

2024

££
Raw materials and consumables42,05034,234
Total42,05034,234
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables25,998691,975
Amounts owed to related parties184,591176,831
Taxation and social security45,840111,344
Other creditors20,83710,312
Accrued liabilities and deferred income509,674342,607
Total786,9401,333,069
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.